(lp0
S"Aradigm Corp.  Announces Mixed Results from Two Pulmaquin Phase 3s in ... StreetInsider.com - Dec 1, 2016 Aradigm Corporation  announced top-line results from its two Phase 3 clinical trials  evaluating the safety and efficacy of Pulmaquin, the Company's investigational proprietary formulation of once daily ciprofloxacin ..."
p1
aS'Aradigm Corp. MarketWatch - Apr 21, 2011 MarketWatch News on ARDM. Aradigm Corp. drops 54% in pre-market trade on results of two late-stage clinical trials. 9:41 a.m.'
p2
aS'6 Reasons Aradigm Corporation Is An Excellent Risk Vs. Reward Opportunity Seeking Alpha  - Aug 8, 2014 Yet, we managed to discover an intriguing biotech small cap with an excellent risk vs. reward profile called Aradigm Corporation . This company possesses exactly the right features that made us aggressively buy shares in the open market:.'
p3
aS"Don't Write Off Aradigm Corporation  Just Yet Market Exclusive - Dec 2, 2016 A number of small cap biotech companies took a hit on their market capitalization on Thursday, but none more sharply than Aradigm Corporation . The company put out some data relating to its lead investigational asset, Pulmaquin, and&nbsp;...Pulmaquin failure halves Aradigm's value - The Pharma Letter "
p4
aS"3 Reasons Why Aradigm Corporation  is a Great Momentum Stock September ... Zacks.com - Sep 22, 2016 This method discovered several great candidates for momentum-oriented investors, but today let's focus in on Aradigm Corporation as this stock is looking especially impressive right now. And while there are numerous ways in which this company could be ..."
p5
aS"Watch-list Mover of Tuesday: Aradigm Corporation's  stock price ends at ... WsNews 4investors - 20 hours ago Aradigm Corporation  stock price tumbled -0.51% to finalize at $1.95 throughout previous buying and selling session. A total of 0.01 million shares exchanged at hands and its average trading volume is standing at 0.07 million shares."
p6
aS"Investors Watch-list: Aradigm Corporation's  stock price settles at $1 ... WsNews 4investors - Mar 14, 2017 Aradigm Corporation  stock price distance from twenty day simple moving average surged at 0.56% while its distance from fifty day simple moving average raised 4.18% along with -50.51% below distance from two hundred simple moving averages."
p7
aS"Top Positive Mover Inside Traders Spotlight: Aradigm Corporation's (ARDM ... WsNews 4investors - Mar 13, 2017 Aradigm Corporation  stock price escalated 6.21% to finalize at $1.88 throughout previous buying and selling session."
p8
aS'Aradigm Announces Completion of Patient Enrollment for Second Phase III Study ... Lung Disease News - Oct 14, 2015 Aradigm Corporation, a pharmaceutical company focused on the development and commercialization of drugs for the prevention and treatment of severe respiratory diseases, recently announced the conclusion of patient enrollment in the ORBIT-3 trial, the&nbsp;...'
p9
aS'A New Kind of Stock Chart: Aradigm Corporation  Critical Pivot Points CML News - Jan 11, 2017 This is a real time view of the critical technical pivot points for Aradigm Corporation  . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.'
p10
a.